Jan 2024 – Present · 2 yrs 3 mos · Vaud, Switzerland · Remote

• As the Founder of The Agency Advantage, I leverage nearly two decades of experience in medical communications and global medical affairs to empower professionals transitioning into the pharmaceutical and biotech industries. Beginning my career as a medical writer, I have advanced to a Global Medical Director role at a Fortune 500 biopharmaceutical company, gaining firsthand insight into the industry's complexities. Through The Agency Advantage, I offer tailored career consultations, comprehensive resources, and expertly curated online courses to demystify the industry. My mission is to unlock your potential and guide you toward your dream career in pharma or biotech.

Dec 2021 – Sep 2023 · 1 yr 9 mos

• Led scientific communications for multiple high-impact global launches, including the European launch of atezolizumab (Tecentriq) for early-stage NSCLC (IMpower010).
• Co-developed 40+ omnichannel assets, including KOL videos, infographics, internal HCP training materials, and congress strategy.
• Led the development and execution of congress planning for the lung franchise, ensuring strategic presence and data dissemination.
• Publication lead for multiple launch and pipeline assets across oncology, neuroscience and rare disease.
• Successes:
• Co-created launch of 40+ omnichannel assets that became the internal gold standard, driving engagement with both oncologists and surgeons (at the time a new audience) and leading to the development of a surgeon communications strategy. Strengthened relationships with key thoracic surgery societies and KOLs.
• For the first time at Roche, successfully navigated legal and compliance barriers to showcase transformative patient videos at AAN, the largest neuroscience conference, demonstrating the real-world impact of risdiplam.
• Curated a mostly female panel for an Alzheimer's scientific symposium, including an up-and-coming neurologist, contributing to her international career development as a rising star in the field.
• Rebuilt trust with a co-development partner after a strained relationship, successfully integrating their extensive network and disease area expertise to enhance engagement and broaden our reach.

Oct 2017 – Dec 2021 · 4 yrs 2 mos

• Led global scientific communications for Roche’s neuromuscular disease franchise, playing a pivotal role in the successful global launch of risdiplam.
• Designed and executed the scientific publications plan, culminating in the pivotal Phase II/III data being published in the New England Journal of Medicine (NEJM).
• Innovated conference engagement strategies, introducing patient video storytelling at AAN for the first time, setting a new standard for audience engagement and patient-centric scientific storytelling.
• Developed and implemented strategic communication initiatives to enhance HCP awareness and advocacy for rare disease treatments.
• Actively contributed to Roche’s internal Publications Policy Awareness group, creating training programs and newsletters to reinforce compliance and excellence in scientific publishing.
• Led the integrated comms team and development of associated plan by bringing together stakeholders from commercial, group comms, medical, policy, access and patient partnering.
• Lifecycle team (LCT) standing member.
• 5 million budget holder for publications, IME, medical education and conferences.

Mar 2016 – Sep 2017 · 1 yr 6 mos · Basel Area, Switzerland

Feb 2015 – Feb 2016 · 1 yr · Milan Area, Italy

Jan 2014 – Feb 2015 · 1 yr 1 mo · Witney

May 2012 – Jan 2014 · 1 yr 8 mos

Mar 2010 – May 2012 · 2 yrs 2 mos

Nov 2009 – Feb 2010 · 3 mos

Jun 2008 – Nov 2009 · 1 yr 5 mos

Jul 2007 – May 2008 · 10 mos

Apr 2005 – Jul 2007 · 2 yrs 3 mos

Mar 2004 – Apr 2005 · 1 yr 1 mo